Adma Biologics reported $568.69M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Adma Biologics USD 568.69M 10.31M Sep/2025
Alnylam Pharmaceuticals USD 4.85B 285.64M Sep/2025
Dynavax Technologies USD 946.51M 28.06M Sep/2025
Takeda JPY 15.41T 938.47B Dec/2025